Literature DB >> 1805046

Prognostic factors for pleural lymphoma patients.

K Aozasa1, M Ohsawa, K Iuchi, T Mori, H Komatsu, K Tajima, K Minato, K Tajima, M Shimoyama.   

Abstract

Prognostic factors in 47 patients with pleural lymphocytic lymphoma developing in chronic tuberculous pyothorax were evaluated using Cox's proportional hazards model. There were 41 men and six women, aged 44-80 (median 61) years. Approximately 70% of the patients had localized disease in Stages I and II, and 30% advanced disease in Stages III and IV. Histologically, 27 patients had the diffuse large, immunoblastic type and 12 had others. In the other seven patients, histological subtyping of the lymphocytic lymphoma was impossible because of degenerative or necrotic changes in the histologic specimens. A diagnosis of lymphocytic lymphoma of B-cell type was made in one case using combined cytologic and surface maker findings on a cell suspension. In addition, immunologic and immunohistochemical studies revealed another 40 cases to be proven B-cell lymphomas. Poor performance status and elevated levels of BUN and GPT were significantly associated with shortened survival in a Cox's proportional hazards model. A poor performance status and high levels of serum BUN and GPT suggested a marked deterioration in a patient's condition. When compared with previous literature describing prognostic factors in patients with B-cell lymphomas and with lymphocytic lymphomas with unfavorable histologies or associated with long-standing inflammations, the only common prognostic factors was performance status. The significance of primary site in predicting survival from lymphocytic lymphoma is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805046

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Pleural non-Hodgkin's lymphoma arising in a patient with a chronic pyothorax.

Authors:  N Y Hsu; C Y Chen; S T Pan; C P Hsu
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

2.  High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.

Authors:  Y Sasajima; H Yamabe; Y Kobashi; K Hirai; S Mori
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

3.  Primary Malignant Lymphoma Originating from the Chest Wall without Preceding Pleural Disease.

Authors:  Yumi Iwasa; Asuka Okada; Hideaki Takenaka; Terukazu Takahashi; Nobuo Koguchi; Kumiko Katayama; Shinsuke Murakami; Sumito Choh; Koichi Tomoda; Hiroshi Kimura
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.